Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple walk and grounding may ease breast cancer symptoms

NCT ID NCT06767059

Symptom relief Sponsor: Ankara University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether walking, with or without a grounding stick, can reduce pain, fatigue, and improve sleep in women with breast cancer. Fifty-five women who were on chemotherapy took part. They walked for 30 minutes at least three times a week for eight weeks. The goal was to see if these simple activities could make daily life a bit easier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
walking and grounding (walking with a grounding stick)
What this could lead to
If it works, this could offer a simple, drug-free way to ease pain, fatigue, and sleep problems during breast cancer treatment.
What could go wrong
This is a small, completed trial with only 55 participants. Results may not apply to all women, and the benefits may be modest or due to the walking itself rather than grounding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

55 people

The number who actually took part.

Started

Jan 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older, * Can read and write and speak Turkish, * Diagnosed with primary breast cancer and know the diagnosis, * Volunteered to participate in the research, * Living in Ankara province, * Paclitaxel or Paclitaxel-Transtuzumab based chemotherapy treatment initiated, * Eastern Cooperative Oncology Group (ECOG) Scale 0 or 1, * NCI-CTCAE v5.0 Pain, fatigue and sleep toxicity grade 1 or 2, * You have a phone with an iOS or Android processor, Exclusion Criteria: * Open wounds or edema of the hands and feet, * NCI-CTCAE v5.0 motor and sensory peripheral neuropathy with toxicity grade 3,4 or 5, * People with a disability that would prevent them from walking, * Diagnosed cardiovascular and pulmonary disorders, * Diagnosed neurological or psychiatric illness, * Communication problems, * Bone metastases, * Bilateral mastectomies, Criteria for Withdrawal from the Study: * Withdrawal from the study at any stage, * Hospitalization, * Failure to follow the guidelines or perform the intervention-walking for 30 minutes at least three times a week or walking plus grounding-in the intervention group, * Starting a regular exercise program during the study period in the control group.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Gazi University Health Research and Application Center Gazi Hospital

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.